• LAST PRICE
    0.3700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.3700
  • Day Range
    ---
  • 52 Week Range
    Low 0.1875
    High 0.9000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSRBT
Shanrong Biotechnology Corp
179.4K
0.0x
---
United StatesWWDH
Worldwide Holdings Delaware Corp
550.0
0.0x
---
United StatesNXMR
Nextmart Inc
220.8K
0.0x
---
United StatesXNNHQ
Xenonics Holdings Inc
30.0
0.0x
---
United StatesACAI
Safeplus International Holdings Ltd
3.2K
0.0x
---
United StatesRGTPQ
RegenETP, Inc
515.6K
-0.1x
---
As of 2024-04-28

Company Information

Shanrong Biotechnology Corp. is a holding company for select biotechnology, health, and wellness operations. The Company owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma) and injectable melatonin composition for the treatment of viral diseases addressing COVID-19 and other viral diseases.

Contact Information

Headquarters
707 Eagleview BlvdEXTON, PA, United States 19341-1159
Phone
610-833-6000
Fax
---

Executives

Chief Executive Officer, Director
Timothy Ringgold
Chief Financial Officer, Secretary, Director
Gina Ringgold
Director
Avraham Gilat

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$179.4K
Revenue (TTM)
$1.3M
Shares Outstanding
484.9K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-3.38
EPS
$-15.40
Book Value
$-11.40
P/E Ratio
0.0x
Price/Sales (TTM)
0.1
Price/Cash Flow (TTM)
---
Operating Margin
-362.96%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.